Akụrụngwa Raw Pharmaceutical CAS 33069-62-4 Paclitaxel Powder Anticancer Paclitaxel

Ozi ngwaahịa

Aha:Paclitaxel

Nọmba CAS:33069-62-4

Usoro kemịkalụ:C47H51NO14

Nkọwapụta:99%-102%

Agba:ọcha ma ọ bụ ihe fọrọ nke nta ka ọ bụrụ ntụ ntụ ọcha

Isi mmalite:Taxus yunnanensis, Taxus chinensis

Ụdị:API

Hande mmepụta okirikiri & ikike

Usoro mmepụta:Ụbọchị 45

Ike mmepụta Hande:500kg / afọ

Ngwa

A na-eji ya na nkà mmụta ọgwụ ma jiri ya mee ihe n'ọtụtụ ebe n'ịgwọ ọrịa kansa ara, ọrịa cancer ovarian, ụfọdụ ọrịa kansa na olu na ọrịa cancer akpa ume.

Akụkọ ihe mere eme nke Hande GMP

1. Na 1996, e guzobere usoro mma ma nweta DMF.

2. Na 2004, FDA on-site nnyocha nwetara CGMP akwụkwọ.

3. Na 2009, a na-enweta paclitaxel semi-synthetic DMF na paclitaxel CEP eke.

4. N'afọ 2011, e nwetara paclitaxel CEP semi-synthetic.

5. Na 2012, gafere nyocha TGA na saịtị, nweta asambodo GMP, wee gafee nyocha nke saịtị FDA.

6. Na 2013, gafere saịtị CGMP.

7. N'afọ 2015, e debanyere aha India na aha Japan.

Ọrụ anyị

1.Ngwaahịa:Nye elu-edu, elu-ọcha osisi wepụ, ọgwụ akụrụngwa, na ọgwụ intermediates.

2.Ọrụ nka:Mwepụta ahaziri iche nwere nkọwa pụrụ iche dị ka ihe ndị ahịa chọrọ.